Ozempic Dosage Chart for Weight Loss
Summary: Ozempic is FDA-approved for type 2 diabetes, not weight loss, but prescribers often titrate it to 2.0 mg off-label for appetite suppression. The standard schedule moves 0.25 to 0.5 to 1.0 to 1.7 to 2.0 mg over roughly 17 weeks.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
The short answer: the FDA-approved Ozempic titration is 0.25 mg weekly for 4 weeks, then 0.5 mg for 4 weeks, then 1.0 mg, then 1.7 mg if needed, with a maximum of 2.0 mg per week [1]. Ozempic is approved for type 2 diabetes, not weight loss. The weight-loss indication for semaglutide belongs to Wegovy, which goes one step higher to 2.4 mg [2]. Prescribers who use Ozempic off-label for weight management generally follow the same step-up schedule and stop at 2.0 mg.
The full chart, what each dose delivers in mL and pen clicks, and the insurance trap that catches off-label users are below.
The off-label reality
Ozempic and Wegovy are the same molecule, semaglutide, made by Novo Nordisk. The FDA approved Ozempic in 2017 for adults with type 2 diabetes to improve glycemic control [1]. Wegovy followed in 2021 for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition [2]. Same active ingredient, different label, different maximum dose.
Wegovy was so popular and so backordered through 2023 and 2024 that prescribers started writing Ozempic for weight loss instead. That use is off-label. It is legal, common, and clinically reasonable, but it is not what the FDA label authorizes. Insurance companies know this, which matters when you read the cost section below.
The Ozempic dosage chart for weight loss
The titration schedule is identical to the diabetes protocol. The only difference between off-label weight-loss use and on-label diabetes use is the goal and the maximum dose the prescriber lands on.
| Phase | Weeks | Weekly dose | Volume per dose | Purpose |
|---|---|---|---|---|
| Initiation | 1 to 4 | 0.25 mg | 0.19 mL | Tolerance only. Not therapeutic. |
| Step 1 | 5 to 8 | 0.5 mg | 0.37 mL | First therapeutic dose. |
| Step 2 | 9 to 12 | 1.0 mg | 0.74 mL | Standard maintenance. |
| Step 3 | 13 to 16 | 1.7 mg | 0.5 mL (2 mg pen) | Higher dose, added 2022. |
| Maximum | 17+ | 2.0 mg | 0.5 mL (2 mg pen) | Ozempic ceiling. |
The 1.7 mg and 2.0 mg doses live in the dedicated 2 mg pen Novo Nordisk released after the FDA approved the higher Ozempic dose in 2022 [1]. The 0.25 and 0.5 mg pen, and the 1 mg pen, hold lower concentrations. You cannot reach 2.0 mg by dialing harder on a 1 mg pen. You need the 2 mg pen.
What each pen actually contains
Novo Nordisk sells Ozempic in three pen strengths. The volumes and dose counts are not intuitive, which is why people keep asking why their pen still looks full after a month.
| Pen | Total semaglutide | Total volume | Concentration | Doses per pen |
|---|---|---|---|---|
| 0.25/0.5 mg pen | 2 mg | 1.5 mL | 1.34 mg/mL | 4 of 0.5 mg, or 8 of 0.25 mg |
| 1 mg pen | 4 mg | 3 mL | 1.34 mg/mL | 4 of 1.0 mg |
| 2 mg pen | 8 mg | 3 mL | 2.68 mg/mL | 4 of 2.0 mg, or 4 of 1.7 mg |
Each pen is designed for four weekly doses, which is why one pen lasts a month at a steady dose [1]. The 0.25/0.5 pen is the exception: the first month at 0.25 mg uses half the pen, the second month at 0.5 mg uses the other half. Some people get two months out of that first pen, which is normal.
Why the pen still looks full
Ozempic pens hold 1.5 to 3 mL of solution, but you only inject a few tenths of a mL each week. After four doses the pen has dispensed somewhere between 0.74 mL and 2.0 mL depending on the strength. The reservoir is intentionally oversized so the dose mechanism can work reliably. Looking at the cartridge and trying to estimate doses by liquid level is a losing game. Trust the dose counter, not your eyes.
You know the pen is empty when you cannot dial your full dose. The dose counter will stop short. At that point you discard the pen in a sharps container, regardless of how much liquid still looks like it is in there.
How many clicks per dose
Ozempic does not have a printed "click chart" the way some auto-injectors do, but each turn of the dose selector advances the dose by a fixed increment. The dose counter shows milligrams, not clicks, so the meaningful number is what the window displays before you press the injection button.
For the 0.25/0.5 mg pen, the dose selector clicks between 0.25 mg and 0.5 mg only. Two clicks from zero gives you 0.5 mg. One click gives you 0.25 mg.
For the 1 mg pen, the dose selector advances in 0.25 mg increments. Four clicks gives you 1.0 mg.
For the 2 mg pen, the dose counter shows 1.0, 1.7, and 2.0 mg as discrete stops. You dial directly to the dose printed on your prescription. The mechanism is calibrated to deliver exactly that amount [1].
The takeaway: ignore "click counting" advice from forums. The dose counter window is the authoritative source. If the number in the window matches your prescribed dose, you have the right amount.
How Ozempic for weight loss compares to Wegovy
Wegovy uses the same active ingredient and almost the same titration schedule, with one extra step.
| Step | Ozempic | Wegovy |
|---|---|---|
| Week 1 to 4 | 0.25 mg | 0.25 mg |
| Week 5 to 8 | 0.5 mg | 0.5 mg |
| Week 9 to 12 | 1.0 mg | 1.0 mg |
| Week 13 to 16 | 1.7 mg | 1.7 mg |
| Week 17+ | 2.0 mg (max) | 2.4 mg (max) |
The 0.4 mg gap at the top is meaningful. In the STEP 1 trial, semaglutide 2.4 mg produced an average 14.9% body-weight reduction over 68 weeks compared with 2.4% on placebo [3]. Ozempic at 2.0 mg does not have a directly comparable weight-loss outcomes trial in non-diabetic adults, which is part of why the FDA did not extend its label to weight management. SUSTAIN-FORTE, the trial that supported the 2.0 mg Ozempic dose, was a diabetes trial focused on A1c, not weight [1].
For most people who can tolerate it, 2.0 mg of Ozempic produces less weight loss than 2.4 mg of Wegovy. The difference is not huge, but it exists. Off-label Ozempic stops short of the dose Novo Nordisk specifically developed for obesity.
What dose for weight loss in practice
Real-world off-label prescribing for weight loss generally lands in one of two patterns.
The first is to titrate all the way to 2.0 mg following the standard schedule and hold there for as long as the weight loss continues. This is what most prescribers do when the goal is maximum appetite suppression and the patient tolerates each step.
The second is to step down on tolerance. If a patient reaches 1.0 mg and is happy with the appetite suppression, has lost meaningful weight, and is not enjoying the GI side effects, the prescriber may hold at 1.0 mg as a maintenance dose. Some clinicians use 0.5 mg or even 0.25 mg as a long-term maintenance dose for patients who are weight-stable and just want to avoid regain.
There is no single "correct" weight-loss dose of Ozempic. The titration target is the highest dose the patient tolerates that produces useful appetite suppression, capped at 2.0 mg by the pen design.
Units versus mg
People who use compounded semaglutide in a vial draw doses on a U-100 insulin syringe, where 100 units equals 1 mL. Ozempic pens do not use units. The pen dose counter shows milligrams directly. The "units" question only comes up for compounded semaglutide, and the conversion depends entirely on the concentration printed on the vial.
For Ozempic, ignore unit math. Read the milligrams in the dose window.
For compounded semaglutide, the math looks like this for a 2.5 mg/mL vial:
mL = mg desired / 2.5
units (U-100) = mL × 100
So 0.5 mg from a 2.5 mg/mL vial is 0.2 mL, or 20 units on a U-100 syringe. A 5 mg/mL vial would deliver the same 0.5 mg dose at 10 units. The number on the vial label is the only number that matters.
Insurance and the off-label problem
Here is where the FDA label difference bites. US insurance plans cover Ozempic when the diagnosis on the prescription is type 2 diabetes. They cover Wegovy when the diagnosis is obesity and the patient meets BMI criteria. Many plans cover one but not the other. Some cover neither without prior authorization.
If your prescriber writes Ozempic with a diagnosis of obesity or "weight management," most commercial plans will deny the prescription, because Ozempic is not FDA-approved for that use. If they write it with a diabetes diagnosis you do not have, that is fraud. The honest path for off-label use is to pay cash, which runs roughly $900 to $1,000 per month at US retail pharmacies as of 2026.
Medicare Part D is forbidden by statute from covering weight-loss drugs at all, with limited exceptions. Some state Medicaid programs cover Wegovy. Most commercial plans require documented BMI, comorbidities, and prior attempts at lifestyle change before approving either Ozempic for diabetes or Wegovy for obesity.
The practical workaround most patients take is to ask for Wegovy if weight loss is the actual goal. Same molecule, same titration, FDA-approved for the indication, and at least some chance of insurance coverage. Ozempic-for-weight-loss is mostly a cash-pay or off-formulary path.
Side effects scale with dose
Nausea, vomiting, diarrhea, and constipation are the most common Ozempic side effects, and they get worse at higher doses. In the STEP 1 trial of semaglutide 2.4 mg for weight loss, 44% of participants reported nausea, 30% diarrhea, and 24% vomiting [3]. Ozempic at 1.0 mg in the SUSTAIN diabetes trials showed lower rates, in the 15 to 20% range for nausea [1].
The four-week step pattern exists specifically to give the gut time to adapt. Patients who jump steps because they want faster weight loss are the ones who drop out within a month from intolerable GI side effects.
What to do if you take too much
Accidental double doses happen. Someone takes their Sunday shot, forgets, and takes another one Tuesday thinking it is their normal day. The most common consequence is severe GI side effects: nausea, vomiting, diarrhea, sometimes lasting several days. Hypoglycemia is a risk if the person is also on insulin or a sulfonylurea, but rare on Ozempic alone [1].
The FDA-recommended action is to monitor the person for signs of overdose, hydrate, and skip the next scheduled dose. Severe vomiting and dehydration are reasons to call your prescriber or seek urgent care. Reports of deliberate overdose are rare in the literature, and most accidental double-dose cases resolve without lasting harm.
Bubbles and missed doses
A small air bubble in the pen cartridge is normal and does not affect the dose, because the pen mechanism delivers a fixed volume from below the air pocket. A large air pocket at the top of the cartridge is not dangerous in subcutaneous injection (unlike intravenous), but if you see one and the pen will not deliver the full dose, prime the pen as the instructions say and inject as usual.
If you miss a dose by fewer than five days, inject as soon as you remember and resume your normal weekly schedule. If you miss by more than five days, skip the missed dose and take the next one on schedule. Do not double up [1]. If you miss two or more consecutive doses, call your prescriber. They may want you to restart titration at a lower step.
Frequently asked questions
- What is the maximum dose of Ozempic for weight loss?
- The Ozempic pen maxes out at 2.0 mg once weekly. Wegovy, the FDA-approved weight-loss version of the same molecule, goes to 2.4 mg.
- How many mL is one Ozempic dose?
- It depends on the dose. 0.25 mg is 0.19 mL, 0.5 mg is 0.37 mL, 1.0 mg is 0.74 mL, and 2.0 mg is 0.5 mL from the higher-concentration 2 mg pen.
- How many doses are in an Ozempic pen?
- Four. The 0.25/0.5 mg pen holds four 0.5 mg doses, or eight 0.25 mg starter doses. The 1 mg and 2 mg pens each hold four weekly doses.
- Does one Ozempic pen last a month?
- Yes. Each pen contains four weekly doses at a single dose strength, so one pen covers a standard four-week month.
- What is the lowest dose of Ozempic?
- 0.25 mg once weekly. It is the starting dose for the first four weeks of titration. It is sub-therapeutic and used only to build GI tolerance.
- Can you take Ozempic more than once a week?
- No. The FDA label specifies once-weekly subcutaneous injection. Semaglutide has a half-life of about a week, which is the entire reason for the weekly schedule.
- How do I know when my Ozempic pen is empty?
- When the dose counter will not advance to your full prescribed dose. The cartridge often still looks like it has liquid, but the pen stops dispensing once the labeled doses are gone.
- What happens if I take a double dose of Ozempic by accident?
- Most people experience worse nausea, vomiting, or diarrhea for a few days. Drink fluids, skip your next scheduled dose, and call your prescriber if symptoms are severe.
- Can I switch from Ozempic to Wegovy at the same dose?
- Yes. If you are stable on Ozempic 1.0 mg, your prescriber can switch you to Wegovy 1.0 mg and continue titrating toward the 2.4 mg weight-loss maximum. The switch needs a new prescription.
- Does Ozempic need separate pen needles?
- Yes. The box does not always include needles. Ozempic uses NovoFine or NovoTwist single-use pen needles, which most pharmacies stock. Confirm before you leave the counter.
Related dose questions
The titration schedule on this page is for the Ozempic pen as Novo Nordisk sells it. If you are using compounded semaglutide from a US compounding pharmacy, the dosing protocol is similar but the volume math depends on the concentration of your vial. The semaglutide side effects page covers what to do when each step makes you feel worse, and the Wegovy coverage page covers the insurance side of switching molecules if cash-pay Ozempic stops being viable.